BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2007
View Archived Issues
Safety and immunogenicity of new oral vaccine against enterotoxigenic E. coli demonstrated in humans
Read More
Novel nanoparticle-based technology ensures effective delivery of therapeutic siRNA in vivo
Read More
Dose-escalation trial to establish optimal dose of AL-02
Read More
Recent patents disclose novel treatment options for cardiovascular disorders
Read More
Recent University of Pittsburgh patent reports novel diagnostic agents for Alzheimer's disease
Read More
Recent patents impart new therapeutic agents for cancer
Read More
Incyte recaps active quarter
Read More
Organon's natural estrogen contraceptive enters phase III trials
Read More
Update on Peptech and EvoGenix merger
Read More
Phase III Revlimid trial halted based on positive findings
Read More
Telomerase activator shows beneficial effects on human aging
Read More
Cyto Pulse and KCC develop DNA vaccine for prostate application
Read More
Tsumura discontinues development of TU-025 in U.S.
Read More
Patient enrollment completed in phase III trial of pirfenidone in IPF patients
Read More
Medarex and Organon announce therapeutic antibody collaboration
Read More
QuatRx licenses becocalcidiol to CollaGenex
Read More
Next-generation nasal spray flu vaccine enters phase I trial
Read More
CF-101 enters clinic for third therapeutic indication
Read More
Efficacy and MOA of BioLineRx's BL-1020 for schizophrenia sought in clinic
Read More
Fast track designation received for romidepsin
Read More
Sirion commences phase III evaluation of two of its compounds
Read More
Tapestry Pharmaceuticals reports update on next-generation taxane
Read More